SPY408.32+8.23 2.06%
DIA327.10+4.32 1.34%
IXIC11,984.52+321.73 2.76%

--KeyBanc Adjusts ResMed's Price Target to $276 from $302, Keeps Overweight Rating

MT Newswires · 04/29/2022 06:01

Please log in to view news